Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Who Cannot Undergo Surgery

A Technology Assessment

Jeffrey A. Tice, MD



In This Article

Abstract and Introduction


The California Technology Assessment Forum (CTAF) was asked to assess the evidence for the use of transcatheter aortic valve replacement for the treatment of patients with aortic stenosis who are not surgical candidates. Aortic stenosis is treated medically until the valve area decreases to a critical point or the patient becomes symptomatic. Because valvular aortic stenosis is primarily a disease of aging, many patients with aortic stenosis have significant co-morbidities that preclude surgical intervention. The FDA recently approved an aortic valve replacement device that can be implanted without requiring a median sternotomy and cardioplegia.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.